期刊文献+

幽门螺杆菌阳性胃溃疡应用序贯疗法和标准三联疗法治疗的比较 被引量:8

Comparison of sequential therapy and standard triple therapy applied in the treatment of helicobacter pylori positive peptic ulcers
下载PDF
导出
摘要 目的比较幽门螺杆菌(Hp)阳性胃溃疡应用序贯疗法和标准三联疗法治疗的效果。方法 96例Hp阳性胃溃疡患者,随机分为对照组和观察组,各48例。对照组采用标准三联疗法治疗,观察组采用序贯疗法治疗,综合评价两组患者的疗效。结果观察组Hp根除率为81.25%,显著高于对照组的58.33%,差异有统计学意义(P<0.05);两组患者的不良反应发生率比较差异无统计学意义(P>0.05)。观察组临床总有效率为81.25%,显著高于对照组的54.17%,差异有统计学意义(P<0.05)。结论序贯疗法治疗Hp阳性胃溃疡的效果优于标准三联疗法,前者在提高Hp根除率、抑制病情复发方面具有优势,且安全性尚可。 Objective To compare the effect of sequential therapy and standard triple therapy applied in the treatment of helicobacter pylori (Hp) positive peptic ulcers. Methods A total of 96 Hp positive peptic ulcers patients were randomly divided into control group and observation group, with 48 cases in each group. The control group received standard triple therapy, and the observation group received sequentiM therapy. Curative effect was comprehensively evaluated in two groups. Results The observation group had obviously higher rate of Hp eradication as 81.25% than 58.33% in the control group, and the difference had statistical significance (P〈0.05). There was no statistically significant difference in incidence of adverse reactions between two groups (P〉0.05). The observation group had obviously higher total clinical effective rate as 81.25% than 54.17% in the control group, and the difference had statistical significance (P〈0.05). Conclusion Sequential therapy provides better effect than standard triple therapy in the treatment of Hp positive peptic ulcers, which has advantages in increasing rate of Hp eradication and inhibiting recurrence of disease, and it is safe.
作者 宋卫红
出处 《中国实用医药》 2017年第4期114-116,共3页 China Practical Medicine
关键词 幽门螺杆菌阳性胃溃疡 序贯疗法 标准三联疗法 Helicobacter pylori positive peptic ulcers Sequential therapy Standard triple therapy
  • 相关文献

参考文献15

二级参考文献89

  • 1李尚勤,孟丽秋.功能性消化不良与幽门螺杆菌感染的相关性研究[J].医学综述,2005,11(10):952-953. 被引量:20
  • 2刘文忠.幽门螺杆菌感染与功能性消化不良[J].临床消化病杂志,2006,18(2):72-74. 被引量:49
  • 3成虹,胡伏莲,李江.幽门螺杆菌耐药性对其根除治疗影响的研究[J].中华医学杂志,2006,86(38):2679-2682. 被引量:97
  • 4袁明华,王华,陈云萍.抗消化性溃疡药物进展[J].新疆医学,2007,37(3):195-196. 被引量:4
  • 5Jafri NS, Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann Intern Med,2008,148(12):923-931.
  • 6陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2009:274.
  • 7中华医学会消化病学分会 幽门螺杆菌学组/幽门螺杆菌科研协作组.第三次全国幽门螺杆菌感染若干问题共识报告.胃肠病学,2008,:42-46.
  • 8Malfertheiner P,Megraud F,O'Morain C,et al.Current concepts in the management of Helicobacter pylori infec-tion:the Maastricht Ⅲ Consensus Report[J].Gut,2007,56(6):771-781.
  • 9Vakil N,Lanza F,Schwartz H,et al.Seven-day therapy for Helicobacter pylori in the United States[J].Aliment Pharmacol Ther,2004,20(1):99-107.
  • 10Kim BG,Lee DH,Ye BD,et al.Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication:neither treatment dura-tion provides acceptable eradication rate in Korea[J].Helicobacter,2007,12(1):31-35.

共引文献157

同被引文献41

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部